United Therapeutics Corporation Revenue 2008–2025
United Therapeutics Corporation reported $3.18B of revenue for fiscal 2025. That was 10.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +114.6%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $3.18B | +10.6% |
| FY 2024 | $2.88B | +23.6% |
| FY 2023 | $2.33B | +20.2% |
| FY 2022 | $1.94B | +14.9% |
| FY 2021 | $1.69B | +13.6% |
| FY 2020 | $1.48B | +2.4% |
| FY 2019 | $1.45B | -11.0% |
| FY 2018 | $1.63B | -5.7% |
| FY 2017 | $1.73B | +7.9% |
| FY 2016 | $1.60B | +9.1% |
| FY 2015 | $1.47B | +13.8% |
| FY 2014 | $1.29B | +15.4% |
| FY 2013 | $1.12B | +21.9% |
| FY 2012 | $916.08M | +23.3% |
| FY 2011 | $743.18M | +25.3% |
| FY 2010 | $592.90M | +65.2% |
| FY 2009 | $358.88M | +27.5% |
| FY 2008 | $281.50M | — |
Source: United Therapeutics Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open UTHR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
United Therapeutics Corporation reported $3.18B of revenue for fiscal 2025. That was 10.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +114.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for United Therapeutics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeUnited Therapeutics Corporation — frequently asked questions
What is United Therapeutics Corporation's revenue?
United Therapeutics Corporation (UTHR) reported revenue of $3.18B for fiscal year 2025, per its SEC filings.
How has United Therapeutics Corporation's revenue changed over time?
Between fiscal 2008 and 2025, UTHR's revenue grew at roughly 15.3% per year (compound annual rate), from $281.50M to $3.18B.
Where does this data come from?
Figures are computed from United Therapeutics Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.